Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
English
Regional settings
Entity•Capital Com UK LimitedAuthorised and regulated by the Financial Conduct Authority (FCA)
Why Capital.com?
About us
Our history
Our offices
Leadership team
Client funds
How Capital.com makes money
Contact us
Terms and policies
Ways to trade
CFD trading
Spread betting
1X
Charges and fees
Professional
Margin Calls
Markets
Shares
Forex
Indices
Commodities
Trading platforms 
Web platform
Mobile apps
MT4
TradingView
Demo
Learn to trade
Essentials of trading
Risk-management guide
Market guides
Trading Strategies
Trading Psychology
Technical analysis
Market analysis
Help
My account

HomeMarketsSharesDiasorin SPA

Trade Diasorin SPA - DIAm CFD

SummaryHistorical Data
Trading Conditions
Spread0.36
Long position overnight fee
Long position overnight fee
Margin. Your investment
€1,000.00
Overnight fee
Charges from full value of position
-0.022091 %
(-€0.88)

Trade size with leverage ~ €5,000.00

Short position overnight fee ~ €4,000.00

-0.022091%
Short position overnight fee
Short position overnight fee
Margin. Your investment
€1,000.00
Overnight fee
Charges from full value of position
-0.000132 %
(-€0.01)

Trade size with leverage ~ €5,000.00

Short position overnight fee ~ €4,000.00

-0.000132%
Overnight fee time21:00 (UTC)
CurrencyEUR
Min traded quantity1
Margin20
Stock exchangeItaly
Commission on trade10%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close95.78
Open95.54
1-Year Change-2.73%
Day's Range94.16 - 96.1

Diasorin Company profile

DiaSorin SpA is an Italian multinational group, specialising in vitro diagnostics. The company develops, produces, and commercialises reagent kits for hospital and private testing laboratories. Additionally, the company serves the immuno- and molecular- diagnostics markets. Founded in 1968, DiaSorin is headquartered in Saluggia, Italy. The biotechnology powerhouse boasts direct and indirect global commercial presence across all continents. The group's business operations are divided into the following segments: the Immunodiagnostics market and the Molecular Diagnostics market. The former provides cutting-edge immunodiagnostics solutions, based on Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA) techniques. The latter offers molecular diagnostics services for infectious diseases and Leukaemia. DiaSorin trades on the Milan Stock Exchange (MTA) under the ticker DIA and is featured in the FTSE Italia Mid Cap Index. Capital.com enables you to browse the DiaSorin share price (DIA) chart in real time and find more investment opportunities within the biotechnology sector.